QuantuMDx Group Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:QuantuMDx Group Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12110
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases, and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT and Q-SEQ. The company’s devices are built using a range of complex technologies such as nanowires, microfluidic technologies and molecular biology technology. It serves clinics, pharmacies, hospitals and labs. The company has operations in the US and Singapore. QuantuMDx is headquartered in Newcastle Upon Tyne, the UK.

QuantuMDx Group Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QuantuMDx Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
QuantuMDx Group Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
QuantuMDx Raises USD8.4 Million in Venture Financing 10
Partnerships 11
QuantuMDx and Global Good Fund Enter into Co-Development Agreement 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Singapore Institute Of Manufacturing Enters Into Research Agreement With QuantuMDx 13
Genome Institute of Singapore Enters Into Co-Development Agreement With QuantuMDx 14
A*STAR Enters Into Co-Development Agreement With QuantuMDx Group 15
Equity Offering 16
QuantuMDx Plans IPO 16
Acquisition 17
QuantuMDx Acquires NorthGene, Provider Of Paternity Testing Services 17
QuantuMDx Group Ltd – Key Competitors 18
QuantuMDx Group Ltd – Key Employees 19
QuantuMDx Group Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Sep 12, 2018: QuantuMDx announces senior management changes 21
Legal and Regulatory 22
Mar 29, 2018: QuantuMDx achieves ISO 13485: 2016 certification 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
QuantuMDx Group Ltd, Medical Equipment, Key Facts, 2017 2
QuantuMDx Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Deals By Market, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
QuantuMDx Raises USD8.4 Million in Venture Financing 10
QuantuMDx and Global Good Fund Enter into Co-Development Agreement 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Singapore Institute Of Manufacturing Enters Into Research Agreement With QuantuMDx 13
Genome Institute of Singapore Enters Into Co-Development Agreement With QuantuMDx 14
A*STAR Enters Into Co-Development Agreement With QuantuMDx Group 15
QuantuMDx Plans IPO 16
QuantuMDx Acquires NorthGene, Provider Of Paternity Testing Services 17
QuantuMDx Group Ltd, Key Competitors 18
QuantuMDx Group Ltd, Key Employees 19
QuantuMDx Group Ltd, Other Locations 20
QuantuMDx Group Ltd, Subsidiaries 20

List of Figures
QuantuMDx Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[QuantuMDx Group Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hovnanian Enterprises Inc:戦略・SWOT・企業財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cajun Industries, LLC:企業の戦略的SWOT分析
    Cajun Industries, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析
    Summary Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain and wound care affliction patients. It offers Calmare, a pain th …
  • Arvind Ltd:企業の戦略・SWOT・財務情報
    Arvind Ltd - Strategy, SWOT and Corporate Finance Report Summary Arvind Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務情報
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • iBio Inc (IBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Hayleys PLC (HAYL.N0000):企業の財務・戦略的SWOT分析
    Summary Hayleys plc (Hayleys) is a diversified company that offers consumer services. The company’s products include purification products, textiles and construction materials, among others. It offers services such as treasury unit, strategic business development unit, corporate communications, corp …
  • Inpex Corp (1605):石油・ガス:M&Aディール及び事業提携情報
    Summary Inpex Corp (Inpex) is an integrated energy company. It explores for, develops and produces oil and natural gas from its assets in domestic and international regions. The company markets crude oil, condensate, natural gas, and LNG. Inpex has working interest in various upstream projects in Eu …
  • J.B. Hunt Transport Services, Inc. (JBHT):企業の財務・戦略的SWOT分析
    J.B. Hunt Transport Services, Inc. (JBHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Zurich Insurance Group Ltd:企業の戦略・SWOT・財務情報
    Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務情報
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SpareBank 1 Nord-Norge:企業の戦略・SWOT・財務分析
    SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Jack Chia Industries (Thailand) Public Company Ltd (JCT):企業の財務・戦略的SWOT分析
    Jack Chia Industries (Thailand) Public Company Ltd (JCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Insys Therapeutics Inc (INSY):製薬・医療:M&Aディール及び事業提携情報
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its flagship prod …
  • Itochu Enex Co Ltd (8133):企業の財務・戦略的SWOT分析
    Itochu Enex Co Ltd (8133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ESSA Pharma Inc (EPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆